Soleil Boughton - Feb 24, 2022 Form 4/A - Amendment Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Legal Officer
Signature
/s/ Soleil Boughton
Stock symbol
HIMS
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
3/17/2022, 07:15 PM
Date Of Original Report
Mar 1, 2022
Previous filing
Feb 8, 2022
Next filing
Mar 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Award $0 +175K +100% $0.00 349K Feb 24, 2022 Class A Common Stock 175K Direct F1
transaction HIMS Stock Option (right to buy) Award $0 +969K +100.15% $0.00 1.94M Feb 24, 2022 Class A Common Stock 969K $5.01 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs"), which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments over 4 years of continuous service, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date to be the next occurring Company Quarterly Vesting Date that occurs on or after the Vesting Commencement Date, subject to the individual's continuous service with the Company.
F2 The number of stock options awarded has been adjusted from the original filing due to administrative error.
F3 The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.